Related Experiment Video
Updated: Mar 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
UCN enhances TGF-beta-mediated mitoinhibition of VSMCs via counteracting TGF-beta-induced cPLA2 expression and
Chao Zhu1, Changchun Cao1, Xiaofei Wang1
1Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular Intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China.
Abstract:
Urocortins (UCNs) and transforming growth factor-beta (TGF-beta) have been demonstrated to participate in various cardiovascular diseases, many of which involve vascular smooth muscle cells (VSMCs) proliferation. Cytosolic phospholipase A2 (cPLA2)-mediated arachidonic acid (AA) release is an important cause of VSMCs proliferation. The work was to investigate the regulation of VSMCs proliferation by UCN/TGF-beta and whether cPLA2 was a link between their signaling pathways. VSMCs proliferation was measured by colorimetric assay and immunofluorescence microscopy. Using cell flow cytometry, the changes in the cell cycle phases were investigated. Lentiviral Vector Particle was performed to overexpress cPLA2 gene. Both UCN and TGF-beta inhibited VSMCs proliferation and an additive effect was observed when the cells were treated with UCN plus TGF-beta. TGF-beta increased the percentage of cells in G1-phase while UCN increased the cell percentage in G2-phase with a concomitant decrease in S-phase. Furthermore, cPLA2 expression was increased by TGF-beta but decreased by UCN and UCN attenuated TGF-beta-induced cPLA2 expression. In primary VSMCs, TGF-beta induced cPLA2 phosphorylation, and this effect was also attenuated by UCN. Similar to UCN, the cPLA2 inhibitor, pyrrophenone (PYR), also played a role in enhancing TGF-beta-mediated mitoinhibition. Inversely, overexpression of cPLA2 eliminated the effect of UCN on the mitoinhibition. The pretreatment with UCN counteracted TGF-beta-mediated cPLA2 expression and activation, thereby contributing to TGF-beta-mediated mitoinhibition of VSMCs.
Insights
Urocortins and TGF-beta inhibit vascular smooth muscle cell proliferation. Urocortins counteract TGF-beta
Area of Science:
- Cardiovascular Biology
- Cell Signaling
- Molecular Medicine
Background:
- Vascular smooth muscle cell (VSMC) proliferation contributes to cardiovascular diseases.
- Cytosolic phospholipase A2 (cPLA2)-mediated arachidonic acid release drives VSMC proliferation.
- Urocortins (UCNs) and transforming growth factor-beta (TGF-beta) are implicated in cardiovascular pathologies.
Purpose of the Study:
- To investigate the regulation of VSMC proliferation by UCN and TGF-beta.
- To determine if cPLA2 acts as a link between UCN and TGF-beta signaling pathways in VSMCs.
Main Methods:
- VSMC proliferation assessed via colorimetric assay and immunofluorescence microscopy.
- Cell cycle analysis performed using flow cytometry.
- cPLA2 gene overexpression achieved using lentiviral vectors; cPLA2 activity inhibited using pyrrophenone (PYR).
Main Results:
- Both UCN and TGF-beta inhibited VSMC proliferation, with an additive effect when combined.
- TGF-beta promoted G1-phase arrest, while UCN induced G2-phase arrest.
- TGF-beta upregulated cPLA2 expression and phosphorylation, whereas UCN downregulated cPLA2 and attenuated TGF-beta's effects.
- Overexpression of cPLA2 abolished UCN's inhibitory effect on proliferation.
Conclusions:
- UCN and TGF-beta exhibit opposing roles in regulating VSMC proliferation via modulation of cPLA2 signaling.
- UCN counteracts TGF-beta-induced VSMC proliferation by inhibiting cPLA2 activation and expression.
- Targeting the UCN-cPLA2-TGF-beta axis may offer therapeutic strategies for cardiovascular diseases involving VSMC proliferation.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Related Concept Videos
TGF - β Signaling Pathway
Mesenchymal Stem Cells
Abnormal Proliferation